Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 110

    1.

    Pulmonary Arterial Hypertension: Baseline Characteristics From the REVEAL Registry.

    Badesch DB, Raskob GE, Elliott CG, Krichman AM, Farber HW, Frost AE, Barst RJ, Benza RL, Liou TG, Turner M, Giles S, Feldkircher K, Miller DP, McGoon M.

    Chest. 2009 Oct 16. [Epub ahead of print]PMID: 19837821 [PubMed - as supplied by publisher]Related articles

    2.

    Adiponectin deficiency: a model of pulmonary hypertension associated with pulmonary vascular disease.

    Summer R, Fiack CA, Ikeda Y, Sato K, Dwyer D, Ouchi N, Fine A, Farber HW, Walsh K.

    Am J Physiol Lung Cell Mol Physiol. 2009 Sep;297(3):L432-8. Epub 2009 Jun 26.PMID: 19561137 [PubMed - indexed for MEDLINE]Related articles

    3.

    ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association.

    McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J; American College of Cardiology Foundation Task Force on Expert Consensus Documents; American Heart Association; American College of Chest Physicians; American Thoracic Society, Inc; Pulmonary Hypertension Association.

    J Am Coll Cardiol. 2009 Apr 28;53(17):1573-619. No abstract available. PMID: 19389575 [PubMed - indexed for MEDLINE]Related articles

    4.

    ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association.

    McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J, Harrington RA, Anderson JL, Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Grines CL, Hlatky MA, Jacobs AK, Kaul S, Lichtenberg RC, Lindner JR, Moliterno DJ, Mukherjee D, Pohost GM, Rosenson RS, Schofield RS, Shubrooks SJ, Stein JH, Tracy CM, Weitz HH, Wesley DJ; ACCF/AHA.

    Circulation. 2009 Apr 28;119(16):2250-94. Epub 2009 Mar 30. Review. No abstract available. Erratum in: Circulation. 2009 Jul 14;120(2):e13. PMID: 19332472 [PubMed - indexed for MEDLINE]Related articles

    5.

    Dosing considerations in the use of intravenous prostanoids in pulmonary arterial hypertension: an experience-based review.

    Oudiz RJ, Farber HW.

    Am Heart J. 2009 Apr;157(4):625-35. Review.PMID: 19332188 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effect of sodium butyrate on lung vascular TNFSF15 (TL1A) expression: differential expression patterns in pulmonary artery and microvascular endothelial cells.

    Safaya S, Klings ES, Odhiambo A, Li G, Farber HW, Steinberg MH.

    Cytokine. 2009 Apr;46(1):72-8. Epub 2009 Feb 28.PMID: 19251437 [PubMed - indexed for MEDLINE]Related articles

    7.

    Propylene glycol accumulation during continuous-infusion lorazepam in critically ill patients.

    Wilson KC, Farber HW.

    J Intensive Care Med. 2008 Nov-Dec;23(6):413; author reply 414-5. No abstract available. PMID: 19019841 [PubMed - indexed for MEDLINE]Related articles

    8.

    Design of the REVEAL registry for US patients with pulmonary arterial hypertension.

    McGoon MD, Krichman A, Farber HW, Barst RJ, Raskob GE, Liou TG, Miller DP, Feldkircher K, Giles S.

    Mayo Clin Proc. 2008 Aug;83(8):923-31.PMID: 18674477 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The status of pulmonary arterial hypertension in 2008.

    Farber HW.

    Circulation. 2008 Jun 10;117(23):2966-8. No abstract available. PMID: 18541751 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Pulmonary arterial hypertension and left-sided heart disease in sickle cell disease: clinical characteristics and association with soluble adhesion molecule expression.

    Klings ES, Anton Bland D, Rosenman D, Princeton S, Odhiambo A, Li G, Bernard SA, Steinberg MH, Farber HW.

    Am J Hematol. 2008 Jul;83(7):547-53.PMID: 18383329 [PubMed - indexed for MEDLINE]Related articles

    11.

    On the importance of plasmalogen status in stimulated arachidonic acid release in the macrophage cell line RAW 264.7.

    Gaposchkin DP, Farber HW, Zoeller RA.

    Biochim Biophys Acta. 2008 Apr;1781(4):213-9. Epub 2008 Feb 20.PMID: 18328831 [PubMed - indexed for MEDLINE]Related articles

    12.

    Identification of oxidative post-translational modification of serum albumin in patients with idiopathic pulmonary arterial hypertension and pulmonary hypertension of sickle cell anemia.

    Odhiambo A, Perlman DH, Huang H, Costello CE, Farber HW, Steinberg MH, McComb ME, Klings ES.

    Rapid Commun Mass Spectrom. 2007;21(14):2195-203.PMID: 17569101 [PubMed - indexed for MEDLINE]Related articles

    13.

    Sarcoidosis-associated pulmonary hypertension: outcome with long-term epoprostenol treatment.

    Fisher KA, Serlin DM, Wilson KC, Walter RE, Berman JS, Farber HW.

    Chest. 2006 Nov;130(5):1481-8.PMID: 17099027 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Conversion to bosentan from prostacyclin infusion therapy in pulmonary arterial hypertension: a pilot study.

    Steiner MK, Preston IR, Klinger JR, Criner GJ, Waxman AB, Farber HW, Hill NS.

    Chest. 2006 Nov;130(5):1471-80.PMID: 17099026 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Heart failure with preserved ejection fraction.

    Fiack CA, Farber HW.

    N Engl J Med. 2006 Oct 26;355(17):1828; author reply 1830-1. No abstract available. PMID: 17065647 [PubMed - indexed for MEDLINE]Related articles

    16.

    Imatinib mesylate in the treatment of refractory idiopathic pulmonary arterial hypertension.

    Patterson KC, Weissmann A, Ahmadi T, Farber HW.

    Ann Intern Med. 2006 Jul 18;145(2):152-3. No abstract available. PMID: 16847299 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Pulmonary hypertension and beta-thalassemia major: report of a case, its treatment, and a review of the literature.

    Tam DH, Farber HW.

    Am J Hematol. 2006 Jun;81(6):443-7.PMID: 16680745 [PubMed - indexed for MEDLINE]Related articles

    18.

    Pulmonary hemodynamic responses to brain natriuretic peptide and sildenafil in patients with pulmonary arterial hypertension.

    Klinger JR, Thaker S, Houtchens J, Preston IR, Hill NS, Farber HW.

    Chest. 2006 Feb;129(2):417-25.PMID: 16478861 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Synthesis and biological properties of the fluorescent ether lipid precursor 1-O-[9'-(1''-pyrenyl)]nonyl-sn-glycerol.

    Zheng H, Duclos RI Jr, Smith CC, Farber HW, Zoeller RA.

    J Lipid Res. 2006 Mar;47(3):633-42. Epub 2005 Dec 20.PMID: 16369049 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.
    21.

    Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.

    Preston IR, Klinger JR, Houtches J, Nelson D, Farber HW, Hill NS.

    Respir Med. 2005 Dec;99(12):1501-10.PMID: 15890512 [PubMed - indexed for MEDLINE]Related articles

    22.

    Differential gene expression in pulmonary artery endothelial cells exposed to sickle cell plasma.

    Klings ES, Safaya S, Adewoye AH, Odhiambo A, Frampton G, Lenburg M, Gerry N, Sebastiani P, Steinberg MH, Farber HW.

    Physiol Genomics. 2005 May 11;21(3):293-8. Epub 2005 Mar 1.PMID: 15741505 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Sickle cell vaso-occlusive crisis induces the release of circulating serum heat shock protein-70.

    Adewoye AH, Klings ES, Farber HW, Palaima E, Bausero MA, McMahon L, Odhiambo A, Surinder S, Yoder M, Steinberg MH, Asea A.

    Am J Hematol. 2005 Mar;78(3):240-2.PMID: 15726596 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Pulmonary arterial hypertension.

    Farber HW, Loscalzo J.

    N Engl J Med. 2004 Oct 14;351(16):1655-65. Review. No abstract available. PMID: 15483284 [PubMed - indexed for MEDLINE]Related articles

    25.

    Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.

    Klings ES, Farber HW.

    N Engl J Med. 2004 Jun 10;350(24):2521-2; author reply 2521-2. No abstract available. PMID: 15190149 [PubMed - indexed for MEDLINE]Related articles

    26.

    HIV-associated pulmonary hypertension: diagnosis and treatment.

    Burkart KM, Farber HW.

    Adv Cardiol. 2003;40:197-207. Review. No abstract available. PMID: 14533555 [PubMed - indexed for MEDLINE]Related articles

    27.

    The pathogenesis of HIV-associated pulmonary hypertension.

    Klings ES, Farber HW.

    Adv Cardiol. 2003;40:71-82. Review. No abstract available. PMID: 14533547 [PubMed - indexed for MEDLINE]Related articles

    28.

    Mycobacterium marinum osteomyelitis.

    Wilson KC, Bielska B, Farber HW.

    Orthopedics. 2003 Mar;26(3):331-2. No abstract available. PMID: 12650330 [PubMed - indexed for MEDLINE]Related articles

    29.

    Increasing plasmalogen levels protects human endothelial cells during hypoxia.

    Zoeller RA, Grazia TJ, LaCamera P, Park J, Gaposchkin DP, Farber HW.

    Am J Physiol Heart Circ Physiol. 2002 Aug;283(2):H671-9.PMID: 12124215 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Gabapentin toxicity requiring intubation in a patient receiving long-term hemodialysis.

    Jones H, Aguila E, Farber HW.

    Ann Intern Med. 2002 Jul 2;137(1):74. No abstract available. PMID: 12093261 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Identification of protein disulfide isomerase as an endothelial hypoxic stress protein.

    Graven KK, Molvar C, Roncarati JS, Klahn BD, Lowrey S, Farber HW.

    Am J Physiol Lung Cell Mol Physiol. 2002 May;282(5):L996-1003.PMID: 11943664 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Cellular glutathione peroxidase deficiency and endothelial dysfunction.

    Forgione MA, Weiss N, Heydrick S, Cap A, Klings ES, Bierl C, Eberhardt RT, Farber HW, Loscalzo J.

    Am J Physiol Heart Circ Physiol. 2002 Apr;282(4):H1255-61.PMID: 11893559 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension.

    Hoeper MM, Galié N, Murali S, Olschewski H, Rubenfire M, Robbins IM, Farber HW, McLaughlin V, Shapiro S, Pepke-Zaba J, Winkler J, Ewert R, Opitz C, Westerkamp V, Vachiéry JL, Torbicki A, Behr J, Barst RJ.

    Am J Respir Crit Care Med. 2002 Feb 1;165(3):341-4.PMID: 11818318 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    HIV-associated pulmonary hypertension.

    Farber HW.

    AIDS Clin Care. 2001 Jun;13(6):53-5, 59. No abstract available. PMID: 11710309 [PubMed - indexed for MEDLINE]Related articles

    35.

    Current management of primary pulmonary hypertension.

    Klings ES, Farber HW.

    Drugs. 2001;61(13):1945-56. Review.PMID: 11708765 [PubMed - indexed for MEDLINE]Related articles

    36.

    Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease.

    Klings ES, Farber HW.

    Respir Res. 2001;2(5):280-5. Epub 2001 Jul 13. Review.PMID: 11686897 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Increased F2 isoprostanes in the acute chest syndrome of sickle cell disease as a marker of oxidative stress.

    Klings ES, Christman BW, McClung J, Stucchi AF, McMahon L, Brauer M, Farber HW.

    Am J Respir Crit Care Med. 2001 Oct 1;164(7):1248-52.PMID: 11673218 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Gas 6 promotes Axl-mediated survival in pulmonary endothelial cells.

    Healy AM, Schwartz JJ, Zhu X, Herrick BE, Varnum B, Farber HW.

    Am J Physiol Lung Cell Mol Physiol. 2001 Jun;280(6):L1273-81.PMID: 11350808 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Lipopolysaccharide binding protein potentiates airway reactivity in a murine model of allergic asthma.

    Strohmeier GR, Walsh JH, Klings ES, Farber HW, Cruikshank WW, Center DM, Fenton MJ.

    J Immunol. 2001 Feb 1;166(3):2063-70.PMID: 11160257 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Induction of endothelial cell cytoplasmic lipid bodies during hypoxia.

    Scarfo LM, Weller PF, Farber HW.

    Am J Physiol Heart Circ Physiol. 2001 Jan;280(1):H294-301.PMID: 11123244 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension.

    Aguilar RV, Farber HW.

    Am J Respir Crit Care Med. 2000 Nov;162(5):1846-50.PMID: 11069824 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    VEGF is deposited in the subepithelial matrix at the leading edge of branching airways and stimulates neovascularization in the murine embryonic lung.

    Healy AM, Morgenthau L, Zhu X, Farber HW, Cardoso WV.

    Dev Dyn. 2000 Nov;219(3):341-52.PMID: 11066091 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Propylene glycol toxicity in a patient receiving intravenous diazepam.

    Wilson KC, Reardon C, Farber HW.

    N Engl J Med. 2000 Sep 14;343(11):815. No abstract available. PMID: 10991709 [PubMed - indexed for MEDLINE]Related articles

    44.

    IV epoprostenol for systemic sclerosis.

    Klings ES, Farber HW.

    Chest. 2000 Sep;118(3):881-2. No abstract available. PMID: 10988225 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia.

    Eberhardt RT, Forgione MA, Cap A, Leopold JA, Rudd MA, Trolliet M, Heydrick S, Stark R, Klings ES, Moldovan NI, Yaghoubi M, Goldschmidt-Clermont PJ, Farber HW, Cohen R, Loscalzo J.

    J Clin Invest. 2000 Aug;106(4):483-91.PMID: 10953023 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Epoprostenol for pulmonary hypertension in scleroderma.

    Klings ES, Farber HW.

    Ann Intern Med. 2000 Jul 18;133(2):158. No abstract available. PMID: 10896643 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Induction of heme oxygenase-1 by hypoxia and free radicals in human dermal fibroblasts.

    Panchenko MV, Farber HW, Korn JH.

    Am J Physiol Cell Physiol. 2000 Jan;278(1):C92-C101.PMID: 10644516 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Systemic sclerosis-associated pulmonary hypertension: short- and long-term effects of epoprostenol (prostacyclin).

    Klings ES, Hill NS, Ieong MH, Simms RW, Korn JH, Farber HW.

    Arthritis Rheum. 1999 Dec;42(12):2638-45.PMID: 10616012 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Prothrombotic mechanisms in primary pulmonary hypertension.

    Farber HW, Loscalzo J.

    J Lab Clin Med. 1999 Dec;134(6):561-6. Review.PMID: 10595782 [PubMed - indexed for MEDLINE]Related articles

    50.

    Identification of an oxygen responsive enhancer element in the glyceraldehyde-3-phosphate dehydrogenase gene.

    Graven KK, Yu Q, Pan D, Roncarati JS, Farber HW.

    Biochim Biophys Acta. 1999 Oct 28;1447(2-3):208-18.PMID: 10542317 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...